Scholars Central

Conference abstractPublished 5 Nov 2018

Enabling a new era of stem cell medicine: A first technology for determining the dose of therapeutic tissue stem cells

Authors: James L Sherley

Asymmetrex LLC, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Adult tissue stem cells have essential roles in the renewal, repair, aging, and diseases (e.g., cancer) of mammalian tissues. These involvements make them the major principle for success in stem cell medicine. Ironically, given their importance, tissue stem cells pose many challenges to scientific investigation and medical use. Their cellular fractions in tissues are extremely low (typically less than 1 per thousand tissue cells), they are difficult to isolate, and it is difficult to expand their numbers by culturing. A particularly troublesome, long-standing barrier to their use has been the lack of a means to count them specifically. This difficulty has persisted for more than half a century because of the well-known lack of specific molecular biomarkers that identify tissue stem cells, but not their more numerous progeny, early committed progenitor cells. Asymmetrex recently solved the specific tissue stem cell counting problem with its AlphaSTEM Test™ technology developed in partnership with computer simulation leader AlphaSTAR Corporation. The new technology can be used to determine the stem cell-specific fraction of complex cell preparations. It can be applied to determine, for the first time, the stem cell-specific dose of stem cell transplantation treatments, including for example hematopoietic stem cells in bone marrow, mobilized peripheral blood, and umbilical cord blood or mesenchymal stem cells derived from bone marrow, adipose tissue, or amniotic fluid. In addition to better informing approved stem cell therapies, dose data will improve the design, optimization, and interpretation of ongoing stem cell transplantation clinical trials. The AlphaSTEM Test™ technology will enable a new era of quantitative measurement of therapeutic tissue stem cells that will greatly accelerate progress in stem cell medicine.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Biotechnology & Biomaterials
  • SubjectBiochemistry & Biotechnology
  • SubjectMaterials Science
  • BylineArticles whose byline prints “James L Sherley”